DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Confavreux C, O'Connor P, Comi G et al.
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Neurol 2014;
13: 247-256
We do not assume any responsibility for the contents of the web pages of other providers.